Acadia pharmaceuticals reports second quarter 2021 financial results

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad), today announced its financial results for the second quarter ended june 30, 2021. “nuplazid performed well in the second quarter of 2021, highlighted by our ability to drive growth while still navigating the continued impact from the pandemic,” said steve davis, chief executive officer. “we recently completed a type a meeting with the fda regarding pimavanserin for dementia-related psychosis and plan to continue our engagem
ACAD Ratings Summary
ACAD Quant Ranking